Aaron T. Gerds, MD, PhD, expands on the potential role of momelotinib in the treatment of patients with myelofibrosis who present with anemia, details the data from MOMENTUM, and explains what FDA approval of momelotinib could mean for the treatment of this patient population.
Related Keywords
Ohio , United States , Cleveland , Aaront Gerds , , Developmental Therapeutics Program , Cleveland Clinic Taussig Cancer Institute , Department Of Hematology , Department Of Medicine , Case Comprehensive Cancer Center , Medical Oncology , Cleveland Clinic Taussig Cancer , Red Cross , Myeloproliferative Neoplasm , News , Cleveland Clinic ,
comparemela.com © 2020. All Rights Reserved.